未登录 Trastuzumab deruxtecan in HER2-expressing gynecologic cancers from DESTINY-PanTumor02: antitumor activity, safety, and exploratory biomarker analyses 曲妥珠单抗德鲁替康在DESTINY-PanTumor02研究中对HER2表达妇科癌症的抗肿瘤活性、安全性和探索性生物标志物分析 Lee, Jung-Yun; Oaknin, Ana; Manso, Luis; Gonzalez-Martin, Antonio; Lugowska, Iwona; Lorusso, Domenica; Banerjee, Susana; Liao, John B.; Lu, Chien-Hsing; Prasongsook, Naiyarat; Melichar, Bohuslav; Anoka, Chiedozie; Jung, Lindsey; Michelini, Flavia; Puvvada, Soham; Meric-Bernstam, Funda; Makker, Vicky 分享 收藏
分享 收藏
Factors affecting health-related quality of life in cervical cancer survivors: a multicenter cross-sectional study in Korea 影响宫颈癌幸存者健康相关生活质量的因素:一项韩国多中心横断面研究 An, Ji-Eun; Kim, Nam Kyeong; Lee, Soo Hyun; Kim, Kyoung-Hoon; Kim, Min Ju; Lee, Ah-Yeon; Hong, Gyeong-U; Sim, Woo-Jeong; Kim, Se Ik; Kong, Tae-Wook; Kwon, Byung Su; Park, Sung Taek; So, Kyeong A.; Lee, Won Moo; Lee, Jung-Yun; Jeong, Dae Hoon; Choi, Min Chul; Choi, Youn Jin; Lee, Jae-Kwan; Min, Kyung-Jin; Yu, Su-Yeon 分享 收藏
分享 收藏
Efficacy of Chemotherapy Following Prior PARP-Inhibitor Treatment in Patients with Ovarian Cancer 卵巢癌患者经PARP抑制剂治疗后化疗的疗效 Kim, Jung Chul; Park, Junsik; Lee, Yong Jae; Nam, Eun Ji; Kim, Sang Wun; Kim, Sung-Hoon; Kim, Young Tae; Kim, Se Ik; Kim, Jae-Weon; Kim, Byoung-Gie; Lee, Jung-Yun 分享 收藏
分享 收藏
分享 收藏
HPK1 inhibitor reinvigorates exhausted tumor-infiltrating CD8+T cells and synergizes with anti-PD-1 inhibitor in endometrial cancer and ovarian cancer Park, Junsik; Lee, Yong Jae; Kim, Sunghoon; Lim, Seungmook; Park, A. Yeong; Eun Kim, Jamie Jae; Lee, Jinhwa; Kim, Sang Wun; Lee, Jung-Yun; Park, Su-Hyung 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Summary of Research: Efficacy of Trastuzumab Deruxtecan in HER2-Expressing Solid Tumors by Enrollment HER2 IHC Status: Post Hoc Analysis of DESTINY-PanTumor02 研究总结: 通过招募HER2 IHC状态: DESTINY-PanTumor02的事后分析,曲妥珠单抗Deruxtecan在HER2-Expressing实体瘤中的疗效 Oaknin, Ana; Lee, Jung-Yun; Makker, Vicky; Oh, Do-Youn; Banerjee, Susana; Gonzalez-Martin, Antonio; Jung, Kyung Hae; Lugowska, Iwona; Manso, Luis; Manzano, Aranzazu; Melichar, Bohuslav; Siena, Salvatore; Stroyakovskiy, Daniil; Fielding, Anitra; Puvvada, Soham; Smith, Ann; Meric-Bernstam, Funda 分享 收藏
Impact of PARP inhibitor maintenance therapy in newly diagnosed advanced epithelial ovarian cancer: A meta-analysis (vol 18, e0294647, 2023) PARP抑制剂维持治疗对新诊断的晚期上皮性卵巢癌的影响:一项Meta分析(卷18,e0294647,2023) Lee, Banghyun; Chang, Suk-Joon; Kwon, Byung Su; Son, Joo-Hyuk; Lim, Myong Cheol; Kim, Yun Hwan; Lee, Shin-Wha; Choi, Chel Hun; Eoh, Kyung Jin; Lee, Jung-Yun; Suh, Dong Hoon; Kim, Yong Beom 分享 收藏
Phase II randomized study of dostarlimab alone or with bevacizumab versus non-platinum chemotherapy in recurrent gynecological clear cell carcinoma (DOVE/APGOT-OV7/ENGOT-ov80) Dodarlimab单独或联合贝伐单抗与非铂类化疗在复发性妇科透明细胞癌中的II期随机研究 (DOVE/APGOT-OV7/ENGOT-ov80) Lee, Jung-Yun; Tan, David; Ray-Coquard, Isabelle; Lee, Jung Bok; Kim, Byoung Gie; Van Nieuwenhuysen, Els; Huang, Ruby Yun-Ju; Tse, Ka Yu; Gonzalez-Martin, Antonio; Scott, Clare; Hasegawa, Kosei; Wilkinson, Katie; Yang, Eun Yeong; Lheureux, Stephanie; Kristeleit, Rebecca 分享 收藏
分享 收藏
Clinical practice guidelines for ovarian cancer: an update to the Korean Society of Gynecologic Oncology guidelines 卵巢癌临床实践指南: 韩国妇科肿瘤学会指南的更新 Lee, Banghyun; Chang, Suk-Joon; Kwon, Byung Su; Son, Joo-Hyuk; Lim, Myong Cheol; Kim, Yun Hwan; Lee, Shin-Wha; Choi, Chel Hun; Eoh, Kyung Jin; Lee, Jung-Yun; Lee, Yoo-Young; Suh, Dong Hoon; Kim, Yong Beom 分享 收藏